Table 2.
Correlation analysis of the immune mediators with anthropometric and metabolic characteristics in a whole-group approach (n = 161).
| Log-transformed scores | ||||||
|---|---|---|---|---|---|---|
| TNFα | IFNγ | IL-10 | IL-6 | IL-4 | IL-2 | |
| BMI (kg.m−2) | 0.116; 0.179 | −0.051; 0.549 | -0.065; 0.442 | 0.025; 0.774 | 0.141; 0.092 | −0.035; 0.658 |
| Body fat (%) | 0.168; 0.051 | −0.057; 0.503 | 0.070; 0.405 | 0.033; 0.702 | 0.078; 0.354 | −0.036; 0.656 |
| W-H ratio (cm) | 0.137; 0.128 | −0.058; 0.508 | −0.157; 0.072 | 0.184; 0.038∗ | 0.152; 0.081 | −0.051; 0.543 |
| Glucose (mg/dL) | −0.067; .439 | 0.072; 0.390 | −0.054; .519 | −0.212; 0.012∗ | −0.045; 0.593 | 0.066; 0.405 |
| TC (mg.dl−1) | −0.043; 0.619 | −0.118; 0.162 | −0.080; 0.344 | 0.068; 0.427 | −0.012; 0.888 | −0.153; 0.053 |
| HDL-c (mg.dl−1) | −0.115; 0.181 | −0.047; 0.581 | 0.068; 0.421 | −0.157; 0.066 | −0.050; 0.556 | −0.071; 0.371 |
| LDL-c (mg.dl−1) | −0.024; 0.784 | −0.063; 0.455 | −0.072; 0.390 | 0.106; 0.215 | 0.009; 0.917 | −0.132; 0.094 |
| TG (mg.dl−1) | 0.085; 0.323 | −0.127; 0.130 | −0.129; 0.124 | 0.073; 0.396 | −0.016; 0.854 | −0.075; 0.347 |
| C-RP (mg.dl−1) | −0.008; 0.931 | 0.058; 0.510 | 0.096; 0.272 | 0.223; 0.011∗ | 0.024; 0.786 | −0.035; 0.675 |
| HbA1c (mg.dl−1) | 0.029; 0.760 | 0.008; 0.925 | −0.038; 0.650 | −0.067; 0.432 | 0.026; 0.759 | 0.005; 0.905 |
| AM (qty) | −0.031; 0.742 | −0.051; 0.579 | 0.000; 0.997 | -0.038; 0.687 | -043; 0.640 | 0.010; 0.905 |
The Pearson correlation tests were used. Data are expressed in correlation index and significance level (r; P). ∗The correlation is significant in the level of 0.05. AM = amount of medicines, BMI = body mass index, C-RP = C-reactive protein, HbA1c = glycated hemoglobin A1c, TC = total cholesterol, TG = triglycerides, and W-H = waist-to-hip.